Santeri A. Pakola

Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer

James H.A. Clubb, Tatiana V. Kudling, Camilla Heiniö et al. · Frontiers in Immunology · 2022 · 47 citations · Full text

Life Sciences, Immunology, Oncology +17

Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression

Tatiana V. Kudling, James H.A. Clubb, Dafne C.A. Quixabeira et al. · OncoImmunology · 2022 · 35 citations · Full text

Medicine, Immunology, Oncology +17

Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers

João M. Santos, Camilla Heiniö, Dafne C.A. Quixabeira et al. · Cells · 2021 · 34 citations · Full text

Medicine, Immunology, Oncology +17

Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial

Santeri A. Pakola, Katriina Peltola, James H.A. Clubb et al. · Clinical Cancer Research · 2024 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial

Matthew S. Block, James H.A. Clubb, Johanna Mäenpää et al. · Nature Communications · 2025 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17